Cancer Bioscience is an open access, single-blind, peer-reviewed journal publishing research on complex biological mechanisms in the initiation, progression, and therapeutic response of cancer. The journal aims to advance knowledge in key areas of molecular and cellular oncology, including the molecular signaling pathways driving tumorigenesis, the interactions within the tumor microenvironment, and the genetic and epigenetic alterations that contribute to cancer development and metastasis. A significant focus will also be placed on the evolving landscape of novel therapeutic strategies, including targeted therapies, immunotherapies, and personalized medicine, to bridge fundamental research with clinical application to improve patient outcomes. The journal will address the latest advancements in cancer biology, emphasizing both basic research and translational studies, and will highlight how these discoveries translate into innovative therapeutic interventions. Contributions will span a wide range of topics, from the cellular mechanisms of carcinogenesis to the emerging fields of precision oncology, immunotherapy, and cancer metabolism.

Key Areas of Focus:

• Cancer Biology: Uncovering the cellular and molecular mechanisms underlying carcinogenesis, tumor initiation, and progression.

• Molecular Oncology: Investigating the genetic and epigenetic alterations that drive cancer, including oncogenes and tumor suppressor genes.

• Tumor Microenvironment: Examining the complex interactions between cancer cells, immune cells, stromal cells, and the extracellular matrix, and their impact on tumor behavior.

• Cancer Immunology: Exploring the immune system's role in cancer progression and response to therapy, including the potential of immunotherapies and checkpoint inhibitors.

• Cancer Metabolism: Investigating the altered metabolic pathways in cancer cells and their therapeutic implications for targeted interventions.

• Cancer Stem Cells: Analyzing the role of cancer stem cells in tumor initiation, metastasis, and resistance to current therapies.

• Targeted Therapy and Drug Discovery: Innovative development of small molecules, biologics, and personalized medicine.

• Cancer Biomarkers: Identifying and validating biomarkers for cancer diagnosis, prognosis, and treatment prediction.

• Cancer Genetics and Epigenetics: Studying the impact of genetic mutations, chromatin remodeling, and non-coding RNAs on cancer biology and therapy response.

• Precision Oncology: Advancing tailored treatment strategies based on genetic profiling and individualized therapeutic approaches.

• Experimental and Translational Research: Bridging the gap between basic research and clinical applications to improve patient outcomes and accelerate therapeutic development.